Show simple item record

dc.contributor.authorEvans, HEL
dc.contributor.authorGalvão, DA
dc.contributor.authorForbes, CC
dc.contributor.authorGirard, D
dc.contributor.authorVandelanotte, C
dc.contributor.authorNewton, RU
dc.contributor.authorVincent, AD
dc.contributor.authorWittert, G
dc.contributor.authorKichenadasse, G
dc.contributor.authorChambers, S
dc.contributor.authorBrook, N
dc.contributor.authorShort, CE
dc.date.accessioned2022-03-04T02:56:16Z
dc.date.available2022-03-04T02:56:16Z
dc.date.issued2021
dc.identifier.issn2072-6694en_US
dc.identifier.doi10.3390/cancers13235925en_US
dc.identifier.urihttp://hdl.handle.net/10072/412927
dc.description.abstractPreliminary research has shown the effectiveness of supervised exercise-based interventions in alleviating sequela resulting from metastatic prostate cancer. However, many individuals encounter barriers that limit the uptake of face-to-face exercise. Technology-enabled interventions offer a distance-based alternative. This pilot study aimed to explore the acceptability, safety and preliminary efficacy of a web-based exercise intervention (ExerciseGuide) in individuals with metastatic prostate cancer. Forty participants (70.2 ± 8.5 years) with metastatic prostate cancer were randomised into the 8-week intervention (N = 20) or a wait-list control (N = 20). The intervention arm had access to a computer-tailored website, personalised exercise prescription and remote supervision. ExerciseGuide was deemed acceptable with a score ≥20 on the client satisfaction questionnaire; however, the usability score was just below the pre-specified score of ≥68 on the software usability scale. There were no serious adverse events reported. Moderate-to-vigorous physical activity levels between baseline and follow-ups were significantly higher (10.0 min per day; 95% CI = (1.3–18.6); p = 0.01) in the intervention group compared to wait-list control. There were also greater improvements in step count (1332; 95% CI = (159–2505); p = 0.02) and identified motivation (0.4, 95% CI = (0.0, 0.7); p = 0.04). Our findings provide preliminary evidence that ExerciseGuide is acceptable, safe and efficacious among individuals with metastatic prostate cancer.en_US
dc.description.peerreviewedYesen_US
dc.languageenen_US
dc.publisherMDPI AGen_US
dc.relation.ispartofpagefrom5925en_US
dc.relation.ispartofissue23en_US
dc.relation.ispartofjournalCancersen_US
dc.relation.ispartofvolume13en_US
dc.subject.fieldofresearchOncology and carcinogenesisen_US
dc.subject.fieldofresearchcode3211en_US
dc.titleAcceptability and preliminary efficacy of a web-and telephone-based personalised exercise intervention for individuals with metastatic prostate cancer: The exerciseguide pilot randomised controlled trialen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Articlesen_US
dcterms.bibliographicCitationEvans, HEL; Galvão, DA; Forbes, CC; Girard, D; Vandelanotte, C; Newton, RU; Vincent, AD; Wittert, G; Kichenadasse, G; Chambers, S; Brook, N; Short, CE, Acceptability and preliminary efficacy of a web-and telephone-based personalised exercise intervention for individuals with metastatic prostate cancer: The exerciseguide pilot randomised controlled trial, Cancers, 2021, 13 (23), pp. 5925en_US
dcterms.licensehttps://creativecommons.org/licenses/by/4.0/en_US
dc.date.updated2022-03-04T01:42:43Z
dc.description.versionVersion of Record (VoR)en_US
gro.rights.copyright© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
gro.hasfulltextFull Text
gro.griffith.authorChambers, Suzanne K.


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record